Free Trial

ATI Physical Therapy (ATIP) Competitors

$4.76
-0.07 (-1.45%)
(As of 05/31/2024 ET)

ATIP vs. CMAX, BKD, HCSG, CMRX, MRNS, DTIL, PLX, BRNS, FORA, and IOBT

Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include CareMax (CMAX), Brookdale Senior Living (BKD), Healthcare Services Group (HCSG), Chimerix (CMRX), Marinus Pharmaceuticals (MRNS), Precision BioSciences (DTIL), Protalix BioTherapeutics (PLX), Barinthus Biotherapeutics (BRNS), Forian (FORA), and IO Biotech (IOBT).

ATI Physical Therapy vs.

CareMax (NASDAQ:CMAX) and ATI Physical Therapy (NYSE:ATIP) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability.

ATI Physical Therapy has a net margin of -8.15% compared to ATI Physical Therapy's net margin of -79.55%. CareMax's return on equity of 0.00% beat ATI Physical Therapy's return on equity.

Company Net Margins Return on Equity Return on Assets
CareMax-79.55% -57.78% -20.64%
ATI Physical Therapy -8.15%N/A -5.04%

ATI Physical Therapy has lower revenue, but higher earnings than CareMax. ATI Physical Therapy is trading at a lower price-to-earnings ratio than CareMax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareMax$751.10M0.01-$683.35M-$172.36-0.02
ATI Physical Therapy$699.02M0.03-$69.79M-$28.92-0.16

CareMax currently has a consensus target price of $45.00, indicating a potential upside of 1,435.84%. Given ATI Physical Therapy's higher probable upside, equities research analysts plainly believe CareMax is more favorable than ATI Physical Therapy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareMax
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
ATI Physical Therapy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

65.9% of CareMax shares are owned by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are owned by institutional investors. 26.9% of CareMax shares are owned by company insiders. Comparatively, 3.3% of ATI Physical Therapy shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

ATI Physical Therapy received 6 more outperform votes than CareMax when rated by MarketBeat users. Likewise, 36.59% of users gave ATI Physical Therapy an outperform vote while only 30.00% of users gave CareMax an outperform vote.

CompanyUnderperformOutperform
CareMaxOutperform Votes
9
30.00%
Underperform Votes
21
70.00%
ATI Physical TherapyOutperform Votes
15
36.59%
Underperform Votes
26
63.41%

In the previous week, CareMax had 1 more articles in the media than ATI Physical Therapy. MarketBeat recorded 2 mentions for CareMax and 1 mentions for ATI Physical Therapy. ATI Physical Therapy's average media sentiment score of 1.43 beat CareMax's score of -1.00 indicating that CareMax is being referred to more favorably in the media.

Company Overall Sentiment
CareMax Positive
ATI Physical Therapy Negative

CareMax has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500.

Summary

ATI Physical Therapy beats CareMax on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATIP vs. The Competition

MetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE Exchange
Market Cap$20.92M$530.27M$5.18B$17.81B
Dividend YieldN/AN/A2.76%3.51%
P/E Ratio-0.169.46121.3624.70
Price / Sales0.030.242,394.8210.16
Price / Cash0.794.8935.6519.14
Price / Book-0.181.895.555.90
Net Income-$69.79M-$225.94M$106.13M$976.46M
7 Day Performance-1.04%1.28%1.15%0.62%
1 Month Performance6.49%-3.64%0.65%3.61%
1 Year Performance-42.62%-18.88%2.68%20.81%

ATI Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMAX
CareMax
3.3423 of 5 stars
$2.97
+2.8%
$45.00
+1,415.2%
-96.8%$11.29M$751.10M-0.021,450Short Interest ↓
Positive News
Gap Down
BKD
Brookdale Senior Living
3.0587 of 5 stars
$6.61
-1.3%
$7.50
+13.5%
+98.5%$1.28B$3.02B-8.5825,200Short Interest ↓
HCSG
Healthcare Services Group
2.4975 of 5 stars
$10.50
-2.1%
$14.50
+38.1%
-19.9%$773.33M$1.67B18.4233,400Positive News
CMRX
Chimerix
4.5046 of 5 stars
$0.94
+0.7%
$8.50
+801.9%
-30.4%$84.48M$41,000.00-1.0172Analyst Upgrade
Short Interest ↓
MRNS
Marinus Pharmaceuticals
4.3583 of 5 stars
$1.54
+2.3%
$13.79
+798.1%
-80.3%$84.32M$30.99M-0.58165Gap Down
DTIL
Precision BioSciences
3.9137 of 5 stars
$12.07
-4.6%
$46.33
+283.9%
-43.9%$83.65M$48.73M-1.62109Analyst Forecast
PLX
Protalix BioTherapeutics
2.5883 of 5 stars
$1.13
-2.6%
$10.00
+785.0%
N/A$82.85M$65.49M28.25208Gap Down
BRNS
Barinthus Biotherapeutics
2.5907 of 5 stars
$2.11
-6.6%
$8.00
+279.1%
N/A$82.35M$800,000.00-1.15130Short Interest ↓
Positive News
FORA
Forian
3.3015 of 5 stars
$2.64
+0.8%
$7.67
+190.4%
+4.4%$82.21M$20.49M26.40102Positive News
IOBT
IO Biotech
2.7791 of 5 stars
$1.24
-3.9%
$9.67
+679.4%
-41.0%$81.70MN/A-0.6668Positive News
Gap Down

Related Companies and Tools

This page (NYSE:ATIP) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners